Figure 3
From: Concurrent ARID1A and ARID1B inactivation in endometrial and ovarian dedifferentiated carcinomas
Kaplan–Meier disease-specific survival analysis comparing the different genetic subgroups of dedifferentiated endometrial carcinoma. ARID1A/ARID1B co-inactivated dedifferentiated endometrial carcinomas showed similarly aggressive clinical behaviour compared with SMARCA4-inactivated or SMARCAB1-inactivated dedifferentiated endometrial carcinomas (P=0.15) (solid black line: ARID1A/ ARID1B co-inactivated tumours; dotted black: SMARCA4 or SMARCB1-inactivated tumours; solid grey line: tumours with intact expression for SMARCA4/SMARCB1/ARID1A/ARID1B).
